China Isotope & Radiation Corporation (HKG:1763)

Market Cap	4.75B
Revenue (ttm)	8.06B
Net Income (ttm)	432.74M
Shares Out	319.87M
EPS (ttm)	1.35
PE Ratio	10.98
Forward PE	n/a
Dividend	0.42 (3.10%)
Ex-Dividend Date	Jun 5, 2025

Volume	817,800
Average Volume	612,600
Open	14.50
Previous Close	14.86
Day's Range	14.14 - 15.02
52-Week Range	9.30 - 15.02
Beta	0.77
RSI	76.51
Earnings Date	May 30, 2025

About China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1983
• Employees: 3,367
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1763

Financial Performance

In 2024, China Isotope & Radiation's revenue was 7.57 billion, an increase of 14.16% compared to the previous year's 6.63 billion. Earnings were 406.65 million, an increase of 9.62%.

Financial numbers in CNY